F12 Mental and behavioural disorders due to use of cannabinoids

(Mental and behavioural disorders due to use of cannabinoids )

Disease of males and females from the section "Mental and behavioural disorders due to psychoactive substance use". Causes not a significant loss of workdays. May be the cause of death.

154 610 people were diagnosed with Mental and behavioural disorders due to use of cannabinoids

94 died with a diagnosis of Mental and behavioural disorders due to use of cannabinoids

0 % disease mortality Mental and behavioural disorders due to use of cannabinoids

Mental and behavioural disorders due to use of cannabinoids is diagnosed to men at 353.05% more often than women

126 654

Men are diagnosed with Mental and behavioural disorders due to use of cannabinoids. For 94 of them, this diagnosis is fatal

0 %

mortality in men with disease Mental and behavioural disorders due to use of cannabinoids

95 90 85 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 0

27 956

Women are diagnosed with Mental and behavioural disorders due to use of cannabinoids There were no deaths.

0 %

mortality in women with disease Mental and behavioural disorders due to use of cannabinoids

Risk group for the disease Mental and behavioural disorders due to use of cannabinoids men aged 15-19 and women aged15-19

The disease is most common in men aged 15-19

In men, the disease is least likely to occur at the age of 0-9, 85+

In women, the disease is least likely to occur at the age of 0-9, 70-74, 80+

The disease is most common in women aged 15-19

Features of the disease Mental and behavioural disorders due to use of cannabinoids

Absence or low individual and social danger

Diagnostics

13 standard for the diagnosis of Mental and behavioural disorders due to use of cannabinoids

Diagnosis Mental and behavioural disorders due to use of cannabinoids on the 6 place in the frequency of diseases in the rubric of other Mental and behavioural disorders due to psychoactive substance use diseases

Most common:

Mental and behavioural disorders due to use of cannabinoids disease on the 8 most dangerous disease in the category of other Mental and behavioural disorders due to psychoactive substance use diseases

Most dangerous:


Treatment

13 standard for the treatment of Mental and behavioural disorders due to use of cannabinoids

18 days required for doctors in inpatient treatment

Less than an hour is required for outpatient treatment

0 medical procedures are provided for the treatment of Mental and behavioural disorders due to use of cannabinoids

Diseases with similar symptoms

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances ,

Disease of males and females from the section "Mental and behavioural disorders due to psychoactive substance use". Causes not a significant loss of workdays. May be the cause of death.

Low risk, sick men and women, any age

Mental and behavioural disorders due to use of opioids

Mental and behavioural disorders due to use of opioids ,

Disease of males and females from the section "Mental and behavioural disorders due to psychoactive substance use". Causes not a significant loss of workdays. May be the cause of death.

Low risk, sick men and women, any age

Somatoform disorders

Somatoform disorders ,

Disease of males and females from the section "Neurotic, stress-related and somatoform disorders". Causes not a significant loss of workdays. May be the cause of death.

Low risk, sick men and women, any age

Other neurotic disorders

Other neurotic disorders ,

Disease of males and females from the section "Neurotic, stress-related and somatoform disorders". Causes not a significant loss of workdays. May be the cause of death.

Low risk, sick men and women, any age

Possible Symptoms